Article info

PDF
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

Authors

  1. Correspondence to David Mesher, Public Health England, Centre for Infectious Disease Surveillance and Control, 61 Colindale Avenue, London NW9 5EQ, UK; david.mesher{at}phe.gov.uk
View Full Text

Citation

Mesher D, Cuschieri K, Hibbitts S, et al
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

Publication history

  • Received 16 September 2014
  • Revised 28 October 2014
  • Accepted 30 October 2014
  • Published in print 1 February 2015.
  • Published online 20 January 2015.
  • Published first 19 November 2014.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.